The forecast for stomach malignant neoplasms mortality among females in Germany indicates a continuous decline from 2024 through 2028, with values decreasing from 2.92 thousand in 2024 to 2.53 thousand in 2028. This represents a steady year-on-year decline. The data from 2023 is missing for exact percentage calculation but assuming a consistent trend from previous years, the compound annual growth rate (CAGR) over the five-year period suggests a gradual reduction in female deaths due to stomach malignant neoplasms.
Future trends to watch for include advancements in medical technology and healthcare policies that could further impact mortality rates. Additionally, an aging population and lifestyle changes might influence future trends and shift these projections. It's crucial to monitor emerging treatments and early detection programs which could enhance survival rates and further reduce mortality figures.
